Mon, Jun 13th, 2022 - 9:31am
April 30, 2022 - 12:24pm | By Ty Schonert
(WDAY) -- The FDA will review COVID-19 vaccines for kids under five in early summer.
The agency will discuss Moderna and Pfizer's shots in June, but an exact date is yet to be determined. The FDA will also consider Novavax's vaccine for adults ages 18 and over on June 7th.
The committee will be meeting on June 28th to talk about whether current COVID-19 vaccines need to be redesigned to focus on mutations of the virus.
